• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Rebif (Interferon Beta-1a) Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013

Summary View



Pregnancy Category C
  • There are no adequate and well-controlled studies in pregnant women.  Rebif should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus…